| MEDI-563, a humanized anti–IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity function R Kolbeck, A Kozhich, M Koike, L Peng, CK Andersson, MM Damschroder, ... Journal of Allergy and Clinical Immunology 125 (6), 1344-1353. e2, 2010 | 655 | 2010 |
| Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study M Castro, SE Wenzel, ER Bleecker, E Pizzichini, P Kuna, WW Busse, ... The Lancet Respiratory Medicine 2 (11), 879-890, 2014 | 564 | 2014 |
| Effect of low concentrations of ozone on inhaled allergen responses in asthmatic subjects NA Molfino, SC Wright, I Katz, S Tarlo, F Silverman, PA McClean, ... The Lancet 338 (8761), 199-203, 1991 | 521 | 1991 |
| Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia M Laviolette, DL Gossage, G Gauvreau, R Leigh, R Olivenstein, R Katial, ... Journal of allergy and clinical immunology 132 (5), 1086-1096. e5, 2013 | 509 | 2013 |
| A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma E Piper, C Brightling, R Niven, C Oh, R Faggioni, K Poon, D She, C Kell, ... European Respiratory Journal 41 (2), 330-338, 2013 | 425 | 2013 |
| Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti–IL-5 receptor α antibody, in a phase I study of subjects with mild asthma WW Busse, R Katial, D Gossage, S Sari, B Wang, R Kolbeck, AJ Coyle, ... Journal of Allergy and Clinical Immunology 125 (6), 1237-1244. e2, 2010 | 398 | 2010 |
| Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma CK Oh, GP Geba, N Molfino European Respiratory Review 19 (115), 46-54, 2010 | 329 | 2010 |
| Respiratory arrest in near-fatal asthma NA Molfino, LJ Nannini, AN Martelli, AS Slutsky New England Journal of Medicine 324 (5), 285-288, 1991 | 287 | 1991 |
| Molecular and clinical rationale for therapeutic targeting of interleukin‐5 and its receptor NA Molfino, D Gossage, R Kolbeck, JM Parker, GP Geba Clinical & Experimental Allergy 42 (5), 712-737, 2012 | 251 | 2012 |
| Genetics of COPD NA Molfino Chest 125 (5), 1929-1940, 2004 | 213 | 2004 |
| A randomized trial of benralizumab, an antiinterleukin 5 receptor α monoclonal antibody, after acute asthma RM Nowak, JM Parker, RA Silverman, BH Rowe, H Smithline, F Khan, ... The American journal of emergency medicine 33 (1), 14-20, 2015 | 206 | 2015 |
| Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind … S Diver, L Khalfaoui, C Emson, SE Wenzel, A Menzies-Gow, ME Wechsler, ... The Lancet Respiratory Medicine 9 (11), 1299-1312, 2021 | 189 | 2021 |
| Use of intravenous pulsed cyclophosphamide in severe, generalized myasthenia gravis L Gustavo De Feo, J Schottlender, NA Martelli, NA Molfino Muscle & Nerve: Official Journal of the American Association of …, 2002 | 182 | 2002 |
| Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in … JM Parker, CK Oh, C LaForce, SD Miller, DS Pearlman, C Le, GJ Robbie, ... BMC pulmonary medicine 11, 1-10, 2011 | 165 | 2011 |
| A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma CK Oh, R Leigh, KK McLaurin, K Kim, M Hultquist, NA Molfino Respiratory research 14, 1-11, 2013 | 138 | 2013 |
| Smoking and idiopathic pulmonary fibrosis CK Oh, LA Murray, NA Molfino Pulmonary medicine 2012, 2012 | 123 | 2012 |
| Cardiovascular safety of high doses of inhaled fenoterol and albuterol in acute severe asthma MT Newhouse, KR Chapman, AL McCallum, RT Abboud, DM Bowie, ... Chest 110 (3), 595-603, 1996 | 113 | 1996 |
| Assessment of airway tone in asthma NA Molfino, AS Slutsky, G Julia-Serda, V Hoffstein, JP Szalai, ... Am Rev Respir Dis 148, 1238-1243, 1993 | 104 | 1993 |
| Treatment of acute severe asthma with inhaled albuterol delivered via jet nebulizer, metered dose inhaler with spacer, or dry powder AC Raimondi, J Schottlender, D Lombardi, NA Molfino Chest 112 (1), 24-28, 1997 | 101 | 1997 |
| The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study SAJ Schmidt, MB Johansen, M Olsen, X Xu, JM Parker, NA Molfino, ... BMJ open 4 (12), e006720, 2014 | 98 | 2014 |
